NCT01776021

Brief Summary

The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

17 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 25, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

April 27, 2015

Status Verified

November 1, 2013

Enrollment Period

1.9 years

First QC Date

January 23, 2013

Last Update Submit

April 24, 2015

Conditions

Keywords

Urinary tract infectionRecurrent urinary tract infectionCranberryPreventionE-coli

Outcome Measures

Primary Outcomes (1)

  • The primary outcome variable will be UTI incidence density, defined as the semi-annualized number of UTIs in each group, adjusted for susceptible time under observation.

    six months

Secondary Outcomes (1)

  • Time from randomization to first clinical UTI. Time from randomization to first clinical UTI w/ pyuria. Time from randomization to first clinical UTI w/ microbiological verification. The fraction of subjects w/ one or more episode(s) of clinical UTI.

    six months

Study Arms (2)

cranberry juice

ACTIVE COMPARATOR

cranberry juice beverage at a dose of one 8 oz. beverage per day for six months

Other: cranberry juice

Placebo

PLACEBO COMPARATOR

placebo beverage at a dose of one 8 oz. beverage per day for six months

Other: placebo beverage

Interventions

cranberry juice beverage at a dose of one 8 oz. beverage per day for six months

cranberry juice

placebo beverage at a dose of one 8 oz. beverage per day for six months

Placebo

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has had at least 2 episodes of a UTI treated by a healthcare professional in the last year and at least 1 treated UTI within the last 6 months.
  • Subject is willing to avoid listed Vaccinium products (including cranberry juice, cranberries, craisins, blueberries, cranberry/blueberry powders, pills, or supplements, probiotics) for 2 weeks prior to enrollment and throughout intervention.
  • Subject agrees to avoid probiotic dietary supplements for 2 weeks prior to enrollment and throughout intervention.
  • Subject agrees to limit all probiotic-containing foods/yogurt and yogurt-containing products to no more than an 8 oz serving/d within 2 weeks prior to enrollment and throughout intervention.
  • Subject is willing to limit all soda, pop or energy drinks (diet or regular sweetened) to \< 20 oz/d within 2 weeks prior to and throughout intervention.

You may not qualify if:

  • Subject has an in-dwelling catheter, polycystic disease, interstitial cystitis, previous urological surgery, stones, or anatomical abnormalities of the urinary tract, spinal cord injury, immuno-compromised conditions, severe renal impairment, or multiple sclerosis.
  • Subject has a history of antibiotic prophylaxis use for UTI. A 2-week washout period prior to enrollment will be allowed.
  • Subject has a body mass index (BMI) \>40.0 kg/m2.
  • Subjects with diabetes mellitus and HbA1C \>8.0% prior to enrollment.
  • Subject has diabetes mellitus treated with insulin.
  • Subject has an active infection or sign/symptoms of an infection (i.e., including a UTI).
  • Subject has used oral anti-coagulants within the last 4 weeks.
  • Subject has a history or presence of cancer in the prior two years, except for nonmelanoma skin cancer.
  • Subject is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Unknown Facility

Chandler, Arizona, 85224, United States

Location

Unknown Facility

Scottsdale, Arizona, 85251, United States

Location

Unknown Facility

San Diego, California, 92123, United States

Location

Unknown Facility

Santa Rosa, California, 95405, United States

Location

Unknown Facility

Denver, Colorado, 80239, United States

Location

Unknown Facility

Edgewater, Florida, 32123, United States

Location

Unknown Facility

Miami, Florida, 33155, United States

Location

Unknown Facility

Summerfield, Florida, 34491, United States

Location

Ocean Spray Cranberries Research Sites

Addison, Illinois, 60101, United States

Location

Unknown Facility

Evanston, Illinois, 60201, United States

Location

Unknown Facility

Edina, Minnesota, 55435, United States

Location

Unknown Facility

Cincinnati, Ohio, 45249, United States

Location

Unknown Facility

Columbus, Ohio, 43212, United States

Location

Unknown Facility

Anderson, South Carolina, 29621, United States

Location

Unknown Facility

Dallas, Texas, 75231, United States

Location

Unknown Facility

Pleasant Grove, Utah, 84062, United States

Location

Unknown Facility

Salt Lake City, Utah, 84124, United States

Location

Related Publications (4)

  • Williams G, Stothart CI, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Nov 10;11(11):CD001321. doi: 10.1002/14651858.CD001321.pub7.

  • Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Apr 17;4(4):CD001321. doi: 10.1002/14651858.CD001321.pub6.

  • Straub TJ, Chou WC, Manson AL, Schreiber HL 4th, Walker BJ, Desjardins CA, Chapman SB, Kaspar KL, Kahsai OJ, Traylor E, Dodson KW, Hullar MAJ, Hultgren SJ, Khoo C, Earl AM. Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infections. BMC Microbiol. 2021 Feb 18;21(1):53. doi: 10.1186/s12866-021-02106-4.

  • Maki KC, Kaspar KL, Khoo C, Derrig LH, Schild AL, Gupta K. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. Am J Clin Nutr. 2016 Jun;103(6):1434-42. doi: 10.3945/ajcn.116.130542.

MeSH Terms

Conditions

Urinary Tract InfectionsInfectionsUrologic DiseasesEscherichia coli Infections

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesEnterobacteriaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and Mycoses

Study Officials

  • Kevin Maki, PhD

    Biofortis Clinical Research, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2013

First Posted

January 25, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2014

Study Completion

April 1, 2015

Last Updated

April 27, 2015

Record last verified: 2013-11

Locations